You just read:

European Medicines Agency (EMA) Accepts BioMarin's Marketing Application for Pegvaliase MAA for Treatment of Phenylketonuria (PKU)

News provided by

BioMarin Pharmaceutical Inc.

Mar 28, 2018, 16:05 ET